The Virginia General Assembly convened on February 14, 2025, to discuss significant updates to the state's medical cannabis program, focusing on labeling and delivery regulations. The meeting highlighted a proposed bill aimed at enhancing patient safety and access to medical cannabis, particularly for those in rural areas.

The bill seeks to improve the clarity of product labeling for edible and topical cannabis products by requiring dosages to be displayed in milligrams. Additionally, inhalable cannabis products will now include the percentage of THC and CBD, making it easier for patients to understand their medication. These changes are designed to ensure that patients can make informed decisions about their treatment options.

Another critical aspect of the bill is the provision for medical cannabis delivery. Currently, many patients live far from dispensing facilities, sometimes over two hours away. The bill allows for the delivery of medical cannabis to patients and their registered agents, ensuring that access is maintained. However, it specifies that deliveries must be made in person and cannot be conducted through third-party services like DoorDash or Uber Eats.

Support for the bill was voiced by various stakeholders, including pharmaceutical processors and advocacy groups, who emphasized the importance of safe delivery methods and clear labeling for patient safety. Several committee members expressed their gratitude for the bill's patron, Delegate Askew, acknowledging the collaborative effort to refine the legislation.

The committee ultimately voted in favor of the bill, with 11 votes for and 2 against, marking a significant step forward in improving the medical cannabis framework in Virginia. The next steps will involve further discussions and potential implementation of the updated regulations.